| Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis P Cortazar, L Zhang, M Untch, K Mehta, JP Costantino, N Wolmark, ... The Lancet 384 (9938), 164-172, 2014 | 4382 | 2014 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 648 | 2013 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 555 | 2015 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 361 | 2017 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 305 | 2018 |
| Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer K Kast, K Rhiem, B Wappenschmidt, E Hahnen, J Hauke, B Bluemcke, ... Journal of medical genetics 53 (7), 465-471, 2016 | 270 | 2016 |
| Hereditary breast and ovarian cancer: new genes, new treatments, new concepts A Meindl, N Ditsch, K Kast, K Rhiem, RK Schmutzler Deutsches Ärzteblatt International 108 (19), 323, 2011 | 250 | 2011 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 189 | 2017 |
| Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary … J Hauke, J Horvath, E Groß, A Gehrig, E Honisch, K Hackmann, ... Cancer medicine 7 (4), 1349-1358, 2018 | 169 | 2018 |
| Dose-dense sequential epirubicin-paclitaxel as preoperative treatment of breast cancer: results of a randomised AGO study M Untch, G Konecny, N Ditsch, Y Sorokina, V Moebus, B Muck, W Kuhn, ... Proc Am Soc Clin Oncol 21 (Part 1), 34a, 2002 | 161 | 2002 |
| The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a … K Rhiem, C Engel, M Graeser, S Zachariae, K Kast, M Kiechle, N Ditsch, ... Breast Cancer Research 14, 1-8, 2012 | 156 | 2012 |
| Abstract s1-11: Meta-analysis results from the collaborative trials in neoadjuvant breast cancer (ctneobc) P Cortazar, L Zhang, M Untch, K Mehta, J Costantino, N Wolmark, ... Cancer Research 72 (24_Supplement), S1-11-S1-11, 2012 | 154 | 2012 |
| Platelet-derived microparticles and coagulation activation in breast cancer patients B Toth, S Liebhardt, K Steinig, N Ditsch, A Rank, I Bauerfeind, ... Thrombosis and haemostasis 100 (10), 663-669, 2008 | 151 | 2008 |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers AC Antoniou, OM Sinilnikova, L McGuffog, S Healey, H Nevanlinna, ... Human molecular genetics 18 (22), 4442-4456, 2009 | 149 | 2009 |
| The association between vitamin D receptor expression and prolonged overall survival in breast cancer N Ditsch, B Toth, D Mayr, M Lenhard, J Gallwas, T Weissenbacher, ... Journal of Histochemistry & Cytochemistry 60 (2), 121-129, 2012 | 147 | 2012 |
| Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1 KB Meyer, M O’Reilly, K Michailidou, S Carlebur, SL Edwards, JD French, ... The American Journal of Human Genetics 93 (6), 1046-1060, 2013 | 142 | 2013 |
| Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and … AB Spurdle, FJ Couch, MT Parsons, L McGuffog, D Barrowdale, MK Bolla, ... Breast Cancer Research 16, 1-16, 2014 | 133 | 2014 |
| Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 123 | 2019 |
| Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort MS Lenhard, S Mitterer, C Kümper, P Stieber, D Mayr, N Ditsch, K Friese, ... European Journal of Obstetrics & Gynecology and reproductive biology 145 (2 …, 2009 | 120 | 2009 |
